1. Home
  2. NRIX vs ASH Comparison

NRIX vs ASH Comparison

Compare NRIX & ASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$14.76

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo Ashland Inc.

ASH

Ashland Inc.

SELL

Current Price

$75.35

Market Cap

3.2B

ML Signal

SELL

Company Overview

Basic Information
Metric
NRIX
ASH
Founded
2009
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Specialty Chemicals
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.2B
IPO Year
2020
2016

Fundamental Metrics

Financial Performance
Metric
NRIX
ASH
Price
$14.76
$75.35
Analyst Decision
Buy
Buy
Analyst Count
14
12
Target Price
$33.50
★ $82.45
AVG Volume (30 Days)
★ 3.4M
645.3K
Earning Date
10-12-2026
11-03-2026
Dividend Yield
N/A
★ 2.22%
EPS Growth
★ N/A
N/A
EPS
★ 3.26
0.43
Revenue
$76,987,000.00
★ $1,824,000,000.00
Revenue This Year
$786.93
$3.97
Revenue Next Year
N/A
$4.29
P/E Ratio
★ $4.52
$175.77
Revenue Growth
★ 99.31
N/A
52 Week Low
$12.61
$48.00
52 Week High
$28.23
$79.50

Technical Indicators

Market Signals
Indicator
NRIX
ASH
Relative Strength Index (RSI) 25.08 55.54
Support Level $14.65 $66.79
Resistance Level $17.47 $78.88
Average True Range (ATR) 1.22 2.19
MACD -0.77 -0.00
Stochastic Oscillator 0.23 43.74

Price Performance

Historical Comparison
NRIX
ASH

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

About ASH Ashland Inc.

Ashland Inc. is a specialty materials company serving markets including pharmaceuticals, personal care, food and beverages, coatings, construction, energy, and electronics. It operates through four segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. Life Sciences contributes the highest revenue, offering functional additives for pharmaceutical and nutrition applications. Personal Care provides ingredients for skin, hair, oral care, and household products, while Specialty Additives supplies performance-enhancing additives for coatings and. Intermediates produce BDO and related derivatives used in polymers, electronics, agriculture, and pharmaceutical applications. The company generates sales across North America, Europe, Asia Pacific, Latin America, and regions.

Share on Social Networks: